Granite Investment Partners, LLC Ligand Pharmaceuticals Inc Transaction History

Granite Investment Partners, LLC

$2.26 Billion
Q3 2024

A detailed history of Granite Investment Partners, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Granite Investment Partners, LLC holds 118,001 shares of LGND stock, worth $13.2 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

118,001

Holding current value

$13.2 Million

% of portfolio

0.52%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$82.7 - $110.11 $9.76 Million - $13 Million	118,001 New	118,001 $11.8 Million
Q1 2021 May 13, 2021	SELL	$99.52 - $215.83 $3.67 Million - $7.97 Million	-36,914 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $4.85 Million - $6.39 Million	-60,248 Reduced 62.01%	36,914 $3.67 Million
Q3 2020 Nov 06, 2020	SELL	$89.56 - $126.72 $9.25 Million - $13.1 Million	-103,244 Reduced 51.52%	97,162 $9.26 Million
Q2 2020 Aug 03, 2020	BUY	$68.28 - $123.65 $11.3 Million - $20.4 Million	165,169 Added 468.74%	200,406 $22.4 Million
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $723,368 - $1.23 Million	11,415 Added 47.92%	35,237 $2.56 Million
Q4 2019 Feb 10, 2020	BUY	$96.94 - $113.59 $859,760 - $1.01 Million	8,869 Added 59.31%	23,822 $2.48 Million
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $8,625 - $12,016	-100 Reduced 0.66%	14,953 $1.49 Million
Q2 2019 Aug 07, 2019	SELL	$107.38 - $129.34 $4.65 Million - $5.6 Million	-43,317 Reduced 74.21%	15,053 $1.72 Million
Q1 2019 May 13, 2019	BUY	$105.93 - $142.47 $5.67 Million - $7.63 Million	53,539 Added 1108.24%	58,370 $7.34 Million
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $620,107 - $1.31 Million	4,831 New	4,831 $656,000
Q2 2018 Aug 06, 2018	SELL	$150.77 - $207.98 $12.5 Million - $17.2 Million	-82,632 Closed	0 $0
Q1 2018 May 04, 2018	SELL	$138.63 - $182.62 $272,546 - $359,030	-1,966 Reduced 2.32%	82,632 $13.6 Million
Q4 2017 Feb 01, 2018	SELL	$128.36 - $147.04 $4.21 Million - $4.82 Million	-32,798 Reduced 27.94%	84,598 $11.6 Million
Q3 2017 Nov 08, 2017	BUY	$120.91 - $137.94 $14.2 Million - $16.2 Million	117,396	117,396 $16 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Account

Granite Investment Partners, LLC Ligand Pharmaceuticals Inc Transaction History